Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Azenta Inc (AZTA)

Azenta Inc (AZTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
IQV
Winners And Losers Of Q4: IQVIA (NYSE:IQV) Vs The Rest Of The Drug Development Inputs & Services Stocks StockStory - Wed Mar 26, 4:03AM CDT

Winners And Losers Of Q4: IQVIA (NYSE:IQV) Vs The Rest Of The Drug Development Inputs & Services Stocks

FTRE : 8.45 (-3.32%)
UFPT : 203.53 (-2.92%)
AZTA : 36.41 (-1.99%)
RGEN : 139.43 (-1.78%)
IQV : 180.02 (-0.76%)
WST
Unpacking Q4 Earnings: West Pharmaceutical Services (NYSE:WST) In The Context Of Other Drug Development Inputs & Services Stocks StockStory - Tue Mar 25, 4:07AM CDT

Unpacking Q4 Earnings: West Pharmaceutical Services (NYSE:WST) In The Context Of Other Drug Development Inputs & Services Stocks

FTRE : 8.45 (-3.32%)
UFPT : 203.53 (-2.92%)
AZTA : 36.41 (-1.99%)
WST : 224.91 (-0.39%)
IQV : 180.02 (-0.76%)
MEDP
Drug Development Inputs & Services Stocks Q4 In Review: Medpace (NASDAQ:MEDP) Vs Peers StockStory - Fri Mar 21, 4:03AM CDT

Drug Development Inputs & Services Stocks Q4 In Review: Medpace (NASDAQ:MEDP) Vs Peers

MEDP : 317.65 (-2.11%)
FTRE : 8.45 (-3.32%)
AZTA : 36.41 (-1.99%)
RGEN : 139.43 (-1.78%)
CRL : 158.25 (-1.92%)
FTRE
Drug Development Inputs & Services Stocks Q4 Results: Benchmarking Fortrea (NASDAQ:FTRE) StockStory - Tue Mar 18, 4:04AM CDT

Drug Development Inputs & Services Stocks Q4 Results: Benchmarking Fortrea (NASDAQ:FTRE)

FTRE : 8.45 (-3.32%)
MEDP : 317.65 (-2.11%)
AZTA : 36.41 (-1.99%)
WST : 224.91 (-0.39%)
IQV : 180.02 (-0.76%)
UFPT
Unpacking Q4 Earnings: UFP Technologies (NASDAQ:UFPT) In The Context Of Other Drug Development Inputs & Services Stocks StockStory - Thu Mar 13, 4:01AM CDT

Unpacking Q4 Earnings: UFP Technologies (NASDAQ:UFPT) In The Context Of Other Drug Development Inputs & Services Stocks

FTRE : 8.45 (-3.32%)
UFPT : 203.53 (-2.92%)
AZTA : 36.41 (-1.99%)
WST : 224.91 (-0.39%)
CRL : 158.25 (-1.92%)
AZTA
Q4 Earnings Recap: Azenta (NASDAQ:AZTA) Tops Drug Development Inputs & Services Stocks StockStory - Wed Mar 12, 4:01AM CDT

Q4 Earnings Recap: Azenta (NASDAQ:AZTA) Tops Drug Development Inputs & Services Stocks

FTRE : 8.45 (-3.32%)
UFPT : 203.53 (-2.92%)
AZTA : 36.41 (-1.99%)
RGEN : 139.43 (-1.78%)
WST : 224.91 (-0.39%)
DY
1 Small-Cap Stock with Exciting Potential and 2 to Brush Off StockStory - Tue Mar 11, 8:03AM CDT

1 Small-Cap Stock with Exciting Potential and 2 to Brush Off

DY : 157.77 (-2.15%)
SLGN : 51.03 (+2.10%)
AZTA : 36.41 (-1.99%)
RGEN
A Look Back at Drug Development Inputs & Services Stocks’ Q4 Earnings: Repligen (NASDAQ:RGEN) Vs The Rest Of The Pack StockStory - Tue Mar 11, 4:01AM CDT

A Look Back at Drug Development Inputs & Services Stocks’ Q4 Earnings: Repligen (NASDAQ:RGEN) Vs The Rest Of The Pack

FTRE : 8.45 (-3.32%)
MEDP : 317.65 (-2.11%)
RGEN : 139.43 (-1.78%)
AZTA : 36.41 (-1.99%)
IQV : 180.02 (-0.76%)
Is the Options Market Predicting a Spike in Azenta (AZTA) Stock?
Is the Options Market Predicting a Spike in Azenta (AZTA) Stock? Zacks Investment Research - Thu Mar 6, 12:12PM CST

Investors in Azenta, Inc. AZTA need to pay close attention to the stock based on moves in the options market lately. That is because the Dec. 19, 2025 $22.5 Call had some of the highest implied volatility...

AZTA : 36.41 (-1.99%)
CRL
Spotting Winners: Charles River Laboratories (NYSE:CRL) And Drug Development Inputs & Services Stocks In Q4 StockStory - Wed Mar 5, 3:01AM CST

Spotting Winners: Charles River Laboratories (NYSE:CRL) And Drug Development Inputs & Services Stocks In Q4

FTRE : 8.45 (-3.32%)
MEDP : 317.65 (-2.11%)
AZTA : 36.41 (-1.99%)
CRL : 158.25 (-1.92%)
IQV : 180.02 (-0.76%)

Barchart Exclusives

This Dividend Stock Yields 5.9%. Should You Buy It Now? Barchart - 1 hour ago
Ford stock offers investors a balance of growth and income. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot